Evergreen Pacific Reinsurance Company Limited ("Evergreen Pacific") announces it is now providing reinsurance coverage for medically prescribed cannabinoid therapeutic treatments to be covered by healthcare insurance plans.
“Evergreen Pacific’s fully integrated solution combines BuyWell.com, a first-of-its-kind ecommerce marketplace for health and wellness products and services, multi-disciplinary medical services, education and training, as well as claims administration and management… Our system will result in better pricing and outcomes for patients.”
Evergreen Pacific Insurance Corporation (“EPIC”), announces it has signed a binding agreement to acquire a majority interest in Synergy Health Services …
Robert Wilson, CEO of Evergreen Pacific Insurance Corporation, commented, “Synergy Health Service’s care philosophy is aligned with EPIC’s focus on improved patient outcomes. We plan to combine our innovative insurance products and other patient-focused resources such as BuyWell.com to improve client experiences.”
“Ultimately, this is all about the patient, and ensuring patients have the information, resources, access to medical practitioners, and through BuyWell.com the health and wellness products and services they need.”
Synergy Health Services Inc. est. 2012, owns and operates multi-disciplinary wellness centres in Ontario, Canada, which provide evidence-based natural healthcare to clients, combining traditional medical pain management with allied health services.
Markers Financial Inc. (“Markers Insurance” or the “Company”), a division of Evergreen Pacific Insurance Corporation (“EPIC”), announces it is introducing Canada’s first guaranteed issue insurance product for individuals providing coverage for medical cannabis prescriptions. In late May, the Company began the process of enrolling licensed producers as medical cannabis suppliers to its e-commerce marketplace, BuyWell.com, and this process is ongoing.
Robert Wilson, Chief Executive Officer of EPIC, commented, “our introduction of insurance coverage for medical cannabis will go a long away toward supporting a more legitimate, patient-centric approach to patient care in Canada. We anticipate a very positive market reception ...”